Dr. Putcha on the Utility of Blood-Based Assays in CRC
Girish Putcha, MD, PhD, discusses the utility of blood-based assays in colorectal cancer.
Dr. Putcha on the Results of the AI EMERGE Trial in CRC
Girish Putcha, MD, PhD, discusses the results of the AI EMERGE trial (NCT03688906) in colorectal cancer.
Dr. Putcha on Blood-Based Detection of Early-Stage CRC
Girish Putcha, MD, PhD, chief medical officer and clinical laboratory director, Freenome, discusses blood-based detection of early-stage colorectal cancer (CRC) using multiomics and machine learning.
Dr. Putcha on the Use of Blood-Based Screening Assays in CRC
Girish Putcha, MD, PhD, discusses the use of blood-based screening assays in colorectal cancer (CRC).
Later-Line Ruxolitinib Use Produces Ongoing Benefit in Real-World Patients With cGVHD
Orca-T Data With Survival, Tolerability Extends to Older Patients With Hematologic Cancers
Dr Ramdial on Gemcitabine/Clofarabine/Busulfan for Lymphoma Stem Cell Transplant
Retrospective Analysis Shows Post-HCT Survival Benefits With Orca-T Vs PTCy in Hematologic Malignancies
2 Commerce Drive Cranbury, NJ 08512